The entire sequence analysis of POT1 in all the study subjects identified only eight variants in high-risk melanoma patients, and only one of these has been predicted as potentially pathogenic, suggesting that POT1 mutations are almost rare [52]. The gene discussed is POT1; the disease is melanoma.